Abstract:Two series of novel naphthalin-containing pyrazoline derivatives C1–C14 and D1–D14 have been synthesized and evaluated for their EGFR/HER-2 inhibitory and anti-proliferation activities. Compound D14 displayed the most potent activity against EGFR and A549 cell line (IC50=0.05μM and GI50=0.11μM), being comparable with the positive control Erlotinib (IC50=0.03μM and GI50=0.03μM) and more potent than our previous compounds C0–A (IC50=5.31μM and GI50=33.47μM) and C0–B (IC50=0.09μM and GI50=0.34μM). Meanwhile, compound C14 displayed the most potent activity against HER-2 and MCF-7 cell line (IC50=0.88μM and GI50=0.35μM), being a little less potent than Erlotinib (IC50=0.16μM and GI50=0.08μM) but far more potent than C0–A (IC50=6.58μM and GI50=27.62μM) and C0–B (IC50=2.77μM and GI50=3.79μM). The docking simulation was performed to analyze the probable binding models and the QSAR models were built for reasonable design of EGFR/HER-2 inhibitors at present and in future. The structural modification of introducing naphthalin moiety reinforced the combination of our compounds and the receptor, resulting in progress of bioactivity. Moreover, the replacement of thiourea skeleton by using benzene ring resulted in the slight diversity of the two series towards specific targets.

Natural Product-Based Design, Synthesis and Biological Evaluation of Anthra[2,1-D]thiazole-6,11-dione Derivatives from Rhein As Novel Antitumour Agents.

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53-MDM2 interaction. Part 2.

Design, Syntheses, and Antitumor Activity of Novel Chromone and Aurone Derivatives.

Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers

Synthesis, Molecular Docking and Antitumor Activity of New Dithiazoles

Synthesis and biological evaluation of cytotoxic activity of novel anthracene L-rhamnopyranosides.

Design, Synthesis and Biological Evaluation of a Series of New Resveratrol Analogues As Potential Anti-Cancer Agents

Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents.

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

Design, synthesis, and biological antitumor evaluation of tetrahydroisoquinoline derivatives

Design, Synthesis And Biological Evaluation Of Novel Bromophenol Derivatives Incorporating Indolin-2-One Moiety As Potential Anticancer Agents

Synthesis and biological evaluation of novel compounds related to 1-arylnaphthalene lignans and isoquinolines.

Design, Synthesis and Evaluation of Novel Diaryl Urea Derivatives As Potential Antitumor Agents.

Synthesis and Biological Evaluation of Polysubstituted 5-Amino-3,7-diphenyl-7h-thiazolo[3,2-a]pyrimidine-6-carbonitriles

Design, synthesis and biological evaluation of valepotriate derivatives as novel antitumor agents

Design, Synthesis, and Biological Evaluation of Novel N-γ-carboline Arylsulfonamides As Anticancer Agents.